The Diabetes Prevention Program: headline results

1 August 2001

journal article
Published by SAGE Publications in British Journal of Diabetes

Vol. 1 (1) , 62-64
https://doi.org/10.1177/14746514010010011001

Abstract

The Diabetes Prevention Program (DPP) was a trial of over 3,000 people with impaired glucose tolerance (IGT) to assess the effect of different interventions on their progression to type 2 diabetes. During an average follow-up period of three years, intensive lifestyle intervention with regular exercise and weight loss reduced the risk of progression to type 2 diabetes by 58%. Treatment with the antihyperglycaemic agent metformin reduced progression to type 2 diabetes by 31%. The DPP has therefore confirmed that rigorous lifestyle management can reduce the risk of type 2 diabetes and also shown that metformin therapy can reduce diabetes risk.

Keywords

This publication has 11 references indexed in Scilit:

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
New England Journal of Medicine, 2001
Effect of metformin on patients with impaired glucose tolerance
Diabetic Medicine, 1999
The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.
Diabetes Care, 1999
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Diabetes Care, 1997
Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study
Diabetes Care, 1997
Metformin
New England Journal of Medicine, 1996
Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy?
The Lancet, 1994
Primary prevention of non‐insulin‐dependent diabetes mellitus
Diabetes/Metabolism Research and Reviews, 1992
Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malm feasibility study
Diabetologia, 1991
Impaired Glucose Tolerance in the U. S. Population
Diabetes Care, 1989